Virpax Pharmaceuticals In...
0.35
0.00 (0.29%)
At close: Jan 15, 2025, 3:59 PM
0.34
-2.06%
After-hours Jan 15, 2025, 07:54 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -0.25 -0.34 -3.31 -7.2 -9.93 -122.27
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 1.94 0.44 1.07 -7.66 -12.46 -270.74
P/FCF Ratio -0.38 -0.41 -2.76 -23.32 -30.09 -179.44
P/OCF Ratio -0.38 -0.41 -2.76 -23.32 -30.09 -179.44
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a n/a n/a -0.37 -0.46 -0.42
Quick Ratio 1.25 6.36 18.96 0.02 0.02 0.05
Current Ratio 1.25 6.36 18.96 0.02 0.02 0.05
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a -129.55 -28.36 -25.53 -175.34
Return on Equity (ROE) -7.85 -1.29 -0.32 1.06 1.26 2.21
Return on Assets (ROA) -1.58 -1.09 -0.31 -9.64 -73.44 -42.94
Return on Capital (ROIC) -8.11 -1.32 -0.32 1.31 1.16 2.20
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a